The Report Metabolic Disorder Therapeutics Market Size, Share & Trends Analysis Report By Route
of Administration, By Disease (Diabetes, Lysosomal Disorders), By Therapy Type,
By Region, and Segment Forecasts, 2019 – 2025
The global Metabolic Disorder Therapeutics
Market size is expected to reach USD 88.93 billion by 2025, according to a new
report by Grand View Research, Inc. The market is anticipated to witness a CAGR
of 7.56% during the estimated period. Rising incidences of diabetes, obesity,
and hypercholesterolemia are expected to drive the market growth. It is
estimated that by 2040, about 1 person in 11 people worldwide is likely to
suffer from one of the aforementioned diseases.
Researchers
estimate that the prevalence of metabolic diseases like obesity and diabetes is
expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin
American countries. This, in turn, will help boost the overall market growth in
the year to come. Furthermore, with better economic stability in developing
countries, demand for novel therapeutics for one-time treatment has increased.
This has made major companies in the global market to invest heavily in R&D
to develop innovative therapy options. All these factors will contribute to the
development of the market.
Access Research Report of Metabolic Disorder Therapeutics Market @
Further key findings
from the study suggest:
· Diabetes segment led the market in 2017, in terms of
revenue generation,owing to higher prevalence and drug usage
· Obesity segment is expected to register a CAGR of 9.27%
over the forecast period owing to increasing prevalence as a result of sedentary
lifestyle changes
· Drug therapy was the most-preferred therapy due to its
high reliability proven success and availability of various types of drugs to
treat metabolic diseases
· The segment is expected to maintain its dominance even
during the forecast years due to the introduction of smart technology to
deliver antidiabetic drug on a regulated basis
· Key companies in this market are Novo Nordisk A/S;Sanofi
S.A.; BoehringerIngelheim GmbH; Eli Lilly and Company; Merck KgaA; Amgen, Inc.;
AstraZeneca PLC; Actelion Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.;Biocon
Ltd.;BioMarinPharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla, Inc.;
and CymaBay Therapeutics, Inc.
· Most of these companies are focusing on strategies, such
as collaborations, expansion of product portfolios, and M&A to maintain
their industry position
· Oral route of administration was the key
revenue-generating segment in 2017owing to its benefits, such as high
reliability and ease of administration
· North America was the largest regional market in 2017 and
will maintain the trend in future due to the presence of key companies and
rising cases of diabetes and obesity
Grand View Research has segmented the global metabolic
disorder therapeutics market on the basis of disease, therapy type, route of administration,
and region:
Metabolic Disorder
Therapeutics Disease Outlook (Revenue, USD Billion, 2014 - 2025)
·
Lysosomal Storage Diseases
o Gaucher’s
Disease
o Metachromatic
Leukodystrophy
o Hurler
- Scheie
o Sanfilipo
A
o Others
·
Diabetes
·
Obesity
·
Inherited Metabolic Disorders
·
Hypercholesterolemia
Metabolic
Disorder Therapy Type Outlook (Revenue, USD Billion, 2014 - 2025)
·
Enzyme Replacement Therapy
·
Cellular Transplantation
·
Small Molecule Based Therapy
·
Substrate Reduction Therapy
·
Gene Therapy
·
Drug Therapy
Metabolic Disorder
Therapeutics Route of Administration Outlook (Revenue, USD Billion, 2014 -
2025)
·
Oral
·
Parenteral
·
Others
Metabolic Disorder
Therapeutics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o Japan
o China
·
Latin America
o Brazil
·
Middle East & Africa
o South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For
More Information: www.grandviewresearch.com
